- Home
- AUPH vs RNP Comparison
AUPH vs RNP Comparison
Compare AUPH & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- RNP
- Stock Information
- Founded
- AUPH 1993
- RNP 2003
- Country
- AUPH Canada
- RNP United States
- Employees
- AUPH N/A
- RNP N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- RNP Investment Managers
- Sector
- AUPH Health Care
- RNP Finance
- Exchange
- AUPH Nasdaq
- RNP Nasdaq
- Market Cap
- AUPH 1.1B
- RNP 1.1B
- IPO Year
- AUPH 1999
- RNP N/A
- Fundamental
- Price
- AUPH $8.13
- RNP $21.34
- Analyst Decision
- AUPH Strong Buy
- RNP
- Analyst Count
- AUPH 2
- RNP 0
- Target Price
- AUPH $11.50
- RNP N/A
- AVG Volume (30 Days)
- AUPH 1.7M
- RNP 117.6K
- Earning Date
- AUPH 05-01-2025
- RNP 01-01-0001
- Dividend Yield
- AUPH N/A
- RNP 7.94%
- EPS Growth
- AUPH N/A
- RNP N/A
- EPS
- AUPH 0.04
- RNP N/A
- Revenue
- AUPH $235,133,000.00
- RNP N/A
- Revenue This Year
- AUPH $13.80
- RNP N/A
- Revenue Next Year
- AUPH $24.57
- RNP N/A
- P/E Ratio
- AUPH $203.13
- RNP N/A
- Revenue Growth
- AUPH 33.97
- RNP N/A
- 52 Week Low
- AUPH $4.71
- RNP $15.52
- 52 Week High
- AUPH $10.67
- RNP $21.27
- Technical
- Relative Strength Index (RSI)
- AUPH 51.32
- RNP 43.40
- Support Level
- AUPH $7.92
- RNP $21.31
- Resistance Level
- AUPH $8.85
- RNP $22.00
- Average True Range (ATR)
- AUPH 0.42
- RNP 0.32
- MACD
- AUPH 0.04
- RNP -0.09
- Stochastic Oscillator
- AUPH 69.72
- RNP 17.09
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.